ELECTIN Capsule 10mg (Fluoxetine Hydrochloride)

Adult dosage

Adults 1. Depression 1) Initial treatment: The initial dose is 20mg of fluoxetine hydrochloride orally once daily in the morning. In controlled clinical trials, doses of 20～80mg daily were administered. If no improvement is observed, an increase in dose may be considered after several weeks. Doses exceeding 20mg daily should be administered twice daily (morning and noon), and the maximum dose of 80mg daily should not be exceeded. The onset of an adequate antidepressant effect may be delayed until 4 weeks or longer after treatment begins. 2) Maintenance/continuation/extended treatment: There are no definitive data on how long patients should be treated with this drug, but psychopharmacologists agree that acute episodes of depression require several months or more of drug therapy. It is not known whether the amount of antidepressant needed to relieve symptoms is the same as that needed to maintain or sustain remission. 2. Bulimia nervosa Administer 60mg of this drug daily. The daily dose should not exceed 80mg. Measure electrolyte levels before starting treatment. 3. Obsessive-compulsive disorder Administer 20～60mg of this drug daily. The daily dose should not exceed 80mg. 4. Premenstrual dysphoric disorder Administer 20mg of this drug daily. Reassess the need for continued treatment after 6 months of treatment. Patients with renal and/or hepatic impairment, patients receiving multiple medications, older adults, and patients with concomitant diseases: Administer a lower dose or reduce the frequency of administration. Adjust the dose as appropriate according to age and symptoms. Switching from MAO inhibitors used to treat psychiatric disorders Allow an interval of at least 14 days between discontinuing an MAO inhibitor used to treat psychiatric disorders and starting treatment with this drug. Conversely, at least 5 weeks must elapse after discontinuing this drug before starting an MAO inhibitor to treat psychiatric disorders. Other MAO inhibitors, such as linezolid or methylene blue This drug should not be initiated in patients receiving linezolid or intravenous methylene blue because of the increased risk of serotonin syndrome. In patients who require more urgent treatment for a psychiatric condition, including hospitalization or other interventions, consider administering treatment. It may be necessary to urgently administer linezolid or intravenous methylene blue to a patient already receiving this drug. If no alternative to linezolid or intravenous methylene blue is available and, for a particular patient, the benefits of treatment with linezolid or intravenous methylene blue are judged to outweigh the risk of serotonin syndrome, discontinue this drug immediately and administer linezolid or intravenous methylene blue. Monitor the patient for symptoms of serotonin syndrome for 5 weeks after administration of linezolid or intravenous methylene blue, or until 24 hours after the last dose, whichever occurs first. Treatment with this drug may be resumed 24 hours after the last dose of linezolid or intravenous methylene blue. The risk associated with administration of methylene blue by non-intravenous routes (oral tablets or local injection), or intravenous administration of this drug at a dose of 1mg/kg or less, is unclear. Nevertheless, clinicians should be aware of the possibility of emergency symptoms of serotonin syndrome with these uses.

This drug is primarily used as an antidepressant to treat psychiatric conditions such as depression. It may increase the risk of suicidal thoughts or behaviors particularly among young patients aged 18 to 24, so careful assessment of the risks and benefits is required when administering it to this age group. Certain patients should not take this medication, such as those with allergies to this drug or its components, patients with severe kidney dysfunction, and those currently using specific types of medications (MAO inhibitors). Additionally, special caution is needed for patients with a history of seizures, suicidal tendencies, mania, heart disease, or liver or kidney dysfunction. Diabetic patients need to monitor blood glucose control, as this medication may alter it, and patients with elevated intraocular pressure or at risk of glaucoma should also be cautious. This drug can cause various side effects, with the most common including headaches, nausea, insomnia, fatigue, and diarrhea. Rarely, serious allergic reactions, bleeding, arrhythmias, or changes in mental status may occur, so if any abnormal symptoms appear, consult a doctor immediately. Abruptly stopping this medication can lead to withdrawal symptoms such as dizziness, sensory abnormalities, anxiety, nausea, tremors, and headaches, so it should be tapered off under a doctor's guidance. This drug may interact with other medications, so patients must inform their physician or pharmacist of any other medications they are taking, or if they plan to start any new medications. Women who are pregnant or breastfeeding should consult with a specialist considering the effects on the fetus or newborn before using this drug. This drug is not recommended for children and adolescents as safety and efficacy have not been established, and elderly patients should use it cautiously. In case of overdose, symptoms such as vomiting, seizures, or heart abnormalities may occur, requiring immediate medical attention. Finally, it is important to keep this medication out of reach of children and not to transfer it to other containers.

Headache, nausea, insomnia, fatigue, diarrhea, anaphylactic reaction, serum sickness, abnormal secretion of antidiuretic hormone, decreased appetite, hyponatremia, anxiety, nervousness, restlessness, tension, decreased libido, sleep disorders, abnormal dreams, depersonalization, elevated mood, happy mood, thought disorder, abnormal libido, bruxism, hypomania, mania, hallucinations, agitation, panic attacks, suicidal impulses and actions, confusion, attention deficit, dizziness, taste disturbance, hypersomnia, drowsiness, tremors, psychomotor agitation, dyskinesia, ataxia, balance disorder, interstitial myoclonus, convulsions, inability to sit still, Buccoglossal syndrome, serotonin syndrome, memory impairment, blurred vision, pupil dilation, palpitations, ventricular arrhythmia, QT prolongation, flushing, hypotension, vasculitis, vasodilation, yawning, shortness of breath, pharyngitis, pulmonary-related events, nosebleeds, vomiting, dyspepsia, dry mouth, dysphagia, esophageal pain, gastrointestinal bleeding, specific hepatitis, rash, urticaria, itching, hyperhidrosis, alopecia, increased tendency for bruising, cold sweat, angioedema, petechiae, phototoxic reaction, purpura, erythema multiforme, arthralgia, myoclonus, myalgia, frequent urination, dysuria, urinary retention, urination disorder, gynecological bleeding, erectile dysfunction, ejaculation disorder, sexual dysfunction, galactorrhea, hyperprolactinemia, priapism, anxious mood, chills, lethargy, abnormal mood, feeling cold, feeling hot, mucosal bleeding, weight loss, abnormal liver function tests, suicidal thoughts, suicidal behavior, fractures, dizziness, sensory impairment, sleep disorders, weakness, agitation, anxiety, tremors, headache, anaphylactoid reaction, gradual systemic response, severe skin, kidney, liver, or pulmonary-related reactions, growth retardation, delayed puberty, Stevens-Johnson syndrome, changes in platelet function, aplastic anemia, atrial fibrillation, cataracts, cerebrovascular accident, cholestatic jaundice, dyskinesia, eosinophilic pneumonia, epithelial necrosis, erythema multiforme, nodular erythema, exfoliative dermatitis, gynecomastia, cardiac arrest, liver failure, necrosis, hypoglycemia, immune-related hemolytic anemia, renal failure, exacerbation of movement disorder, optic neuritis, pancreatitis, pancytopenia, pulmonary embolism, pulmonary hypertension, thrombocytopenia, thrombocytopenic purpura, ventricular tachycardia, vaginal bleeding, aggressive behavior

This drug should be stored in a tightly sealed container to prevent exposure to air or moisture. Moreover, it is important to maintain a temperature between 1 and 30 degrees Celsius while storing the medication, which helps to keep its efficacy intact for a longer period.

Appearance

A green capsule filled with white or gray-white powder

Package unit

30 capsules/bottle, 300 capsules/bottle